Regulatory T cell: a protection for tumour cells
Open Access
- 28 February 2012
- journal article
- review article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 16 (3), 425-436
- https://doi.org/10.1111/j.1582-4934.2011.01437.x
Abstract
Characterized by immunosuppression regulatory T cells (Tregs) play a key role in maintaining immune tolerance. A growing number of tumours have been found with Tregs accumulating in microenvironment and patients with high density of Tregs in tumour stroma get a worse prognosis, which suggests that Tregs may inhibit anti‐tumour immunity in stroma, resulting in a poor prognosis. In this paper, we demonstrate the accumulation of Tregs in tumour stroma and the possible suppressive mechanisms. We also state the immunotherapy that has being used in animal and clinical trials.Keywords
This publication has 120 references indexed in Scilit:
- Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL–RANK signallingNature, 2011
- IL-35-mediated induction of a potent regulatory T cell populationNature Immunology, 2010
- Intraepithelial Effector (CD3+)/Regulatory (FoxP3+) T-Cell Ratio Predicts a Clinical Outcome of Human Colon CarcinomaGastroenterology, 2009
- TGFβ in CancerCell, 2008
- How regulatory T cells workNature Reviews Immunology, 2008
- Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patientsCancer Immunology, Immunotherapy, 2006
- Cytotoxic T lymphocyte–induced killing in the absence of granzymes A and B is unique and distinct from both apoptosis and perforin-dependent lysisThe Journal of cell biology, 2006
- Functional significance of the perforin/granzyme cell death pathwayNature Reviews Immunology, 2002
- Mouse and human dendritic cell subtypesNature Reviews Immunology, 2002
- Transforming growth factor-β in T-cell biologyNature Reviews Immunology, 2002